Investor AB
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Investor AB reported 7 stock positions worth $14.4 billion. Its top holding was Astrazeneca (AZN) at 67.9% of the portfolio, followed by Nasdaq (NDAQ, 32.0%) and Mediwound (MDWD, 0.1%). Compared with Q1 2026, it opened 1 new position, sold out of 4 and added to 2. The biggest buy was a new position in Micron Technology (MU) and the biggest sale an exit from Coherent (COHR).
- Most Recent 13F
- Q2 2026
- Location
- STOCKHOLM, V7
- CIK
- 0000889232
- Portfolio Value
- $14.4B (Q2 2026)
- SEC Filing
- 0001493152-26-038312 ↗ filed Aug 14, 2026
Holdings Value
Holdings 7 stocks · $14.4B
| AZN Astrazeneca PLC | 67.92% | 51,587,810 | $9.8B | No change |
| NDAQ Nasdaq Inc. | 31.98% | 58,439,208 | $4.6B | Add +0.1% |
| MDWD Mediwound Ltd. | 0.09% | 872,093 | $12.8M | No change |
| CLBT Cellebrite Di Ltd. | 0.01% | 75,000 | $1.1M | Add +36.4% |
| MU Micron Technology Inc. | 0.00% | 470 | $543K | New |
| VZ Verizon Communications Inc. | 0.00% | 11,300 | $478K | No change |
| BMRN Biomarin Pharmaceutical Inc. | 0.00% | 3,700 | $212K | No change |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 7 | $14.4B | AZN, NDAQ, MDWD, CLBT, MU |
| Q1 2026 | 10 | $15.1B | AZN, NDAQ, MDWD, CLBT, COHR |
| Q4 2025 | 12 | $5.7B | NDAQ, MDWD, COF, COHR, CELLEBRITE DI LTD |
| Q3 2025 | 12 | $5.2B | NDAQ, MDWD, MCHP, TER, CHKP |
| Q2 2025 | 13 | $5.2B | NDAQ, MDWD, MCHP, TIGO, CDNS |
| Q1 2025 | 13 | $4.4B | NDAQ, MDWD, TIGO, CDNS, MCHP |
| Q4 2024 | 8 | $4.5B | NDAQ, MDWD, CHKP, CLBT, CCL |
| Q3 2024 | 7 | $4.3B | NDAQ, MDWD, CHKP, ONTO, COHR |
| Q2 2024 | 6 | $3.5B | NDAQ, ONTO, CHKP, CCL, COHR |
| Q1 2024 | 10 | $3.7B | NDAQ, MU, AMAT, ONTO, CHKP |